STEAP2 and thyroid gland papillary carcinoma: Conversely, in a study in papillary thyroid cancer (PTC), low level of STEAP2 correlated with aggressiveness, and METTL3-mediated STEAP2 mRNA stabilization decreased PTC progression [224].